Opioid addiction in pregnancy

Obstetrical and Gynecological Survey

Volumn 67, Issue 12, 2012, Pages 817-825

  Shainker, Scott A ^a   Saia, Kelley ^a   Lee Parritz, Aviva ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BUPRENORPHINE; METHADONE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN;

ANALGESIA; APGAR SCORE; BIRTH WEIGHT; BREAST FEEDING; CESAREAN SECTION; COMORBIDITY; DISEASE SEVERITY; DRUG DETOXIFICATION; DRUG OVERDOSE; DRUG USE; EPIDURAL ANESTHESIA; FEEDING; FETUS BREATHING; FETUS HEART RATE; FETUS MONITORING; FETUS MOVEMENT; FETUS RISK; GESTATIONAL AGE; HEALTH HAZARD; HEPATITIS B; HEPATITIS C; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFANT MORTALITY; INTRAPARTUM CARE; LOW BIRTH WEIGHT; MAINTENANCE DRUG DOSE; MAINTENANCE THERAPY; METHADONE TREATMENT; NOCICEPTION; OBSTETRIC ANESTHESIA; OPIATE ADDICTION; PATIENT CONTROLLED ANALGESIA; POLYPHARMACY; POSTPARTUM PAIN; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL DEVELOPMENT; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGIONAL ANESTHESIA; REVIEW; RISK FACTOR; SMALL FOR DATE INFANT; SUDDEN INFANT DEATH SYNDROME; VERTICAL TRANSMISSION; VIRUS LOAD; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; BREAST FEEDING; BUPRENORPHINE; FEMALE; HUMANS; INFANT, NEWBORN; METHADONE; NEONATAL ABSTINENCE SYNDROME; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PAIN MANAGEMENT; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84872842734     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e3182788e8c     Document Type: Review

References (65)

1. Pregnancy and Illicit Drug Use. National Household Survey on Drug Abuse. Substance Abuse and Mental Health Services Administration. Available at: http://www.samhsa.gov/data/2k2/PregDU/PregDU.pdf. Accessed January 20, 2012.
2. Pregnant Women in Substance Abuse Treatment: 2002. Drug and Alcohol Services Information System. Substance Abuse and Mental Health Services Administration. Available at: http://www.samhsa.gov/data/2k4/pregTX/pregTX.htm. Accessed January 20, 2012.
3. Kellogg A, Rose CH, Harms R, et al. Current trends in narcotic use in pregnancy and neonatal outcomes. Am J Obstet Gynecol. 2011;2.4:259.e1-259.e4.
4. Drug and Alcohol Services Information System. Substance Abuse and Mental Health Services Administration. Characteristics of Primary Prescription and OTC Treatment Admissions: 2002. Available at: http://www.oas.samhsa.gov/2k4/ prescriptionTX/prescription.pdf. Accessed January 30, 2012.
5. Griffith P, Gossop M, Powis B, et al. Transitions in patterns of heroin administration: injectors. Addiction. 1994;89:301-309.
6. Cleary BJ, Donnelly JM, Strawbridge JD, et al. Methadone and perinatal outcomes: a retrospective cohort study. Am J Obstet Gynecol. 2011;204:139.e1-139.e9.
7. Fajemirokun-Odudeyi O, Sinha C, Tutty S, et al. Pregnancy outcome in women who use opiates. Eur J Obstet Gynecol Reprod Biol. 2006;126:170-175.
8. Ohto H, Terazawa S, Sasaki N, et al. Transmission of hepatitis C virus from mother to infants. N Engl J Med. 1994;330: 744-750.
9. Viral hepatitis in pregnancy. American College of Obstetrics and Gynecology Practice Bulletin 86. Obstet Gynecol. 2007 Oct;110(4):941-56.
10. Connor EM, Sperling RS, Gelber R, et al. Reduction ofmaternalinfect transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173-1180.
11. Scheduled cesarean delivery and the prevention of vertical transmission of HIV infection. American College of Obstetrics and Gynecology Committee Opinion 234. Int J Gynaecol Obstet. 2001 Jun;73(3):279-81.
12. Cavanaugh CE, Hedden SL, Latimer WW. Sexually transmitted infections among pregnant heroin-or cocaine-addicted women in treatment: the significance of psychiatric co-morbidity and sex trade. Int J STD AIDS. 2010;21:141-142.
13. Darke S, Torok M, Kaye S, et al. Comparative rates of violent crime among regular methamphetamine and opioid users: offending and victimization. Addiction. 2010;105:916-919.
14. Najavits LM., Weiss RD, Shaw SR. The link between substance abuse and posttraumatic stress disorder in women. Am J Addict. 1997;6:273-283.
15. Dube SR, Felitti VJ, Dong M, et al. Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the Adverse Childhood Experiences Study. Pediatrics. 2003;111: 564-572.
16. Almario CV, Seligman NS, Dysart KC, et al. Risk factors of preterm birth among opiate-addicted gravid women in a methadone treatment program. Am J Obstet Gynecol. 2009; 201:3265.e1-3265.e6.
17. Hulse GK, Milne DR, English DR, et al. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction. 1997;92:1571-1579.
18. Mayet S, Groshkova T, Morgan L, et al. Drugs and pregnancyV outcomes of women engaged with a perinatal outreach addictions service. Drug Alcohol Rev. 2008;27:497-503.
19. Alto WA, O'Connor AB. Management of women treated with buprenorphine during pregnancy. Am J Obstet Gynecol. 2011;205:302-308.
20. Burns L, Conroy E, Mattick RP. Infant mortality among women on a methadone program during pregnancy. Drug Alcohol Rev. 2010;29:551-556.
21. American Academy of Pediatrics Committee on Drugs. Neonatal drug withdrawal. Pediatrics. 1998;101:1079-1088.
22. Kraft WK, Dysart K, Greenspan JS, et al. Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome. Addiction. 2010;106:574-580.
23. Jones HE, Johnson RE, Jasinski DR, et al. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects of the neonatal abstinence syndrome. Drug Alcohol Depend. 2005;79:1-10.
24. Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363:2320-2331.
25. Berghella V, Lim PJ, Hill MK, et al. Maternal methadone dose and neonatal withdrawal. Am J Obstet Gynecol. 2003;189: 312-317.
26. Isemann R, Meinzen-Derr J, Akinbi H. Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome. J Perinatol. 2011; 31:25-29.
27. Seligman NS, Almario CV, Hayes EJ, et al. Relationship between maternal methadone dose at delivery and neonatal abstinence syndromes. J Pediatr. 2010;157:428-433.
28. Cleary BJ, Donnelly J, Strawbridge J, et al. Methadone dose and neonatal abstinence syndrome-systemic review and meta-analysis. Addiction. 2010;105:2071-2084.
29. McCarthy JJ, LaemonMH, ParrMS, et al. High-dosemethadone maintenance in pregnancy: maternal and neonatal outcomes. Am J Obstet Gynecol. 2005;193:606-610.
30. Nanovskaya TN, Deshmukh SV, Miles R, et al. Transfer of L-alpha-acetylmethadol (LAAM) and L-alpha-acetyl-N-normethadol (norLAAM) by the perfused human placental lobule. J Pharmacol Exp Ther. 2003;306:205-212.
31. Nanovskaya T, Deshmukh S, Brooks M, et al. Transplacental transfer and metabolism of buprenorphine. J Pharmacol Exp Ther. 2002;300:26-33.
32. Mattick RP, Breen C, Kimber J, et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009:(3;) CD002209.
33. Zuspan FP, Gumpel JA, Mejia-Zelaya A, et al. Fetal stress from methadone withdrawal. Am J Obstet Gynecol. 1975; 122:43-46.
34. Rementeria J, Nunag NN. Narcotic withdrawal in pregnancy: stillbirth incidence with a case report. Am J Obstet Gynecol. 1973;116:1152-1156.
35. Luty J, Nikolaou V, Bearn J. Is opiate detoxification unsafe in pregnancy? J Subst Abuse Treat. 2003;24:363-367.
36. Dashe JS, Jackson GL, Olscher DA, et al. Opioid detoxification in pregnancy. Obstet Gynecol. 1998;92:854-858.
37. Maas U, Kattner E, Weingart-Jesse B, et al. Infrequent neonatal withdrawal following maternal methadone detoxification during pregnancy. J Perinat Med. 1990;18:111-118.
38. Opioid Abuse, Dependence, and Addiction in Pregnancy. American College of Obstetrics and Gynecology Committee Opinion 524. Obstet Gynecol. 2012 May;119(5):1070-6.
39. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA. 1998;280:1936-1943.
40. Methadone. National Library of MedicineVHazardous Substances Database. Available at: http://toxnet.nlm.nih.gov/cgibin/sis/search/f?./temp/~RaXGIa:1. Accessed February 2, 2012.
41. McCarthy JJ, Leamon MH, Stenson G, et al. Outcomes of neonates conceived on methadone maintenance therapy. J Subst Abuse Treat. 2008;35:202-206.
42. Jansson LM, Dipietro JA, Velez M, et al. Maternal methadone dosing schedule and fetal neurobehavior.Matern Fetal Neonatal Med. 2009;22:29-35.
43. Nekhayeva IA, Nanovskaya TN, Deshmukh SV, et al. Bidirectional transfer of methadone across human placenta. Biochem Pharmacol. 2005;69:187-197.
44. Jansson LM, DiPietro J, Elko A. Fetal response to maternal methadone administration. Am J Obstet Gynecol. 2005;193: 611-617.
45. Archie CL, Lee M, Sokol RJ, et al. The effects of methadone treatment on the reactivity of the nonstress test. Obstet Gynecol. 1989;74:254-255.
46. Wouldes TA, Roberts AB, Pryor JE, et al. The effect of methadone treatment on the quantity and quality of human fetal movement. Neurotoxicol Teratol. 2004;26:23-34.
47. Cejtin HE, Mills A, Swift EL. Effect of methadone on the biophysical profile. J Reprod Med. 1996;41:819-822.
48. Anyaegbunam A, Tran T, Jadali D, et al. Assessment of fetal well-being in methadone-maintained pregnancies: abnormal nonstress tests. Gynecol Obstet Invest. 1997;43:25-28.
49. Jones HE, O'Grady KE, Tuten M. Reinforcement-based treatment improves the maternal treatment and neonatal outcomes of pregnant patients enrolled in comprehensive care treatment. Am J Addict. 2011;20:196-204.
50. Buprenorphine Drug Label. Food and Drug Administration. Available at: http://www.fda.gov/Drugs/DrugSafety/Postmarket DrugSafetyInformationforPatientsandProviders/ucm191520.htm. Accessed April 9, 2012.
51. Lacroix I, Berrebi A, Chaumerliac C, et al. Buprenorphine in pregnant opioid-dependent women: first results of a prospective study. Addiction. 2004;99:209-214.
52. Kakko J, Heilig M, Sarman I. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Drug Alcohol Depend. 2008;96:69-78.
53. Meyer M, Wagner K, Benvenuto A, et al. Intrapartum and postpartum analgesia for women maintained on methadone during pregnancy. Obstet Gynecol. 2007;110:261-266.
54. Jones HE, O'Grady K, Milio L, et al. Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy. Am J Drug Alcohol Abuse. 2009;35:151-156.
55. JonesHE, JohnsonRE,Milio L.Post-cesareanpainmanagement of patients maintained on methadone or buprenorphine. Am J Addict. 2006;15:258-259.
56. Kuczkowski KM. Anesthetic implications of drug abuse in pregnancy. J Clin Anesth. 2003;15:382-394.
57. Breastfeeding:maternal and infant aspects. American College of Obstetrics and Gynecology Committee Opinion 361. Obstet Gynecol. 2007 Feb;109(2 Pt 1):479-80.
58. The transfer of drugs and other chemicals into human milk. American Academy of Pediatrics: Committee on Drug. Pediatrics. 2001;108:776-789.
59. The transfer of drugs and other chemicals into human milk. American Academy of Pediatrics: Committee on Drug. Pediatrics. 1994;93:136-150.
60. Jansson LM, Choo RE, Harrow C, et al. Concentrations of methadone in breast milk and plasma in the immediate perinatal period. J Hum Lact. 2007;23:184-190.
61. Jansson LM, Choo R, Velex ML, et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics. 2008; 121:106-114.
62. Dryden C, Young D, Hepburn M. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG. 2009;116:665-671.
63. Abdel-Latif ME, Pinner J, Clews S, et al. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics. 2006; 117:e1163Ye1169.
64. Lindemalm S, Nydert P, Svensson JO, et al. Transfer of buprenorphine into breast milk and calculation of infant drug dose. J Hum Lact. 2009;25:199-205.
65. Wachman EM, Byun J, Philipp BL. Breastfeeding rates among mothers of infants with neonatal abstinence syndrome. Breastfeed Med. 2010;5:159-164.